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Incorporation of Proteins into Complex Coacervates
Whitney C. Blocher McTigue and Sarah L. Perry
wblocher@umass.edu and perrys@engin.umass.edu

Abstract:
Complex coacervates have found a renewed interest in the past few decades in various fields
such as food and personal care products, membraneless cellular compartments, the origin of life,
and, most notably, as a mode of transport and stabilization of drugs. Here, we describe general
methods for characterizing the phase behavior of complex coacervates and quantifying the
incorporation of proteins into these phase separated materials.
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Introduction
The encapsulation of proteins and other biomacromolecules is an area of tremendous activity, as
such materials are finding increasing utility in applications such as drug delivery, environmental
remediation, personal care products and biocatalysis. Proteins are generally very sensitive to
their environment, and typical methods used for encapsulation can decrease or even destroy the
activity of these molecules. Complex coacervation is a method that can be used to encapsulate
proteins without using harsh conditions that may denature the protein cargo. This method of
sequestration is a viable platform for a variety of different areas such as food science,1,2 personal
care products,3,4 and medicine,5 because of the ability to generate biocompatible formulations
and drive high levels of encapsulation without the need of organic solvents.6-9
Complex Coacervation and Protein Incorporation
Complexation occurs when oppositely charged polyelectrolytes interact under favorable
conditions such that the electrostatic attraction and entropic gains can drive phase separation.
Coacervation is a purely aqueous strategy that can also be leveraged for the triggerable release
protein cargo.10-12 These materials are versatile and have been shown usable for various delivery
techniques such as an injectable protein carrier13-15 and for oral delivery.16,17 This method will
focus on using complex coacervation as an aqueous protein encapsulation technique, and
experimental strategies related to characterizing the concentration of protein present in such
formulations.
Complex Coacervate Phase Behavior
There are many variables that alter the ability of polyelectrolytes to undergo complex
coacervation, including the salt concentration, pH, charge density and chemistry of the polymers,
etc. Here, we will describe an experimental strategy for characterizing aspects of the phase
behavior of complex coacervates, without consideration for other formulation-relevant questions
such as the size and temporal stability of a dispersion of coacervate droplets etc. One
consequence of this experimental focus is the use of concentration on an ionizable monomer
basis, rather than units of mass of polymer per volume that are more typical when considering
polymeric materials. Furthermore, this discussion assumes that the coacervate materials in
question are able to fully equilibrate (i.e., form liquid droplets, rather than kinetically-trapped
gels or solid complexes).
Complex coacervation involves the interaction of oppositely-charged polyelectrolytes. Thus,
while physical and chemical aspects of the polymer such as length, charge density and/or degree
of ionization, as well as hydrophobicity can modulate the phase behavior, we can typically rely
on general intuition regarding electrostatic effects and charge neutrality. For complex
coacervation, the ability to phase separate will be maximized when an equal number of
oppositely-charged groups are present. While this condition may be straightforward to predict
with some simple polymer systems, factors such as pH-dependent degree of ionization can play a
role. These effects are highlighted in Figure1a,b, which show schematic depictions of a two
dimensional phase diagram as a function of the concentration of polycation and polyanion, with
the concentration of salt present in the system defining the contours. The height (i.e., salt
stability) of the two-phase region is maximized along the line of equimolar charge (black line).
For systems where all of the potentially ionizable monomers are charged, this results in a
symmetric phase diagram (Figure 1a). However, if the pH of the solution has been changed such
that only half of the ionizable groups on one of the polymers are charged (e.g., the apparent pKa

of the polycation), then the phase diagram becomes asymmetric, as in Figure 1b.

Figure 1: A schematic contour plot of the three-dimensional phase envelope for complex coacervation as a function of relative
polycation concentration, polyanion concentration, and salt concentration (shown as contours) for (a) a system where the relative
degree of ionization of the polycation and polyanion is the same, and (b) a system where the relative degree of ionization for the
polycation is half that of the polyanion. The black line in both plots indicates the salt-polymer phase behavior for a mixture of
equal numbers of ionized cationic and anionic species, shown as the binodal curve in (c). The grey line traces out the effect of
changing the charge stoichiometry of the system. (c) A schematic illustration of a typical salt versus polymer concentration phase
diagram defined by the black lines in (a,b). Coacervation occurs in the two-phase region beneath the binodal curve. A sample
prepared within this two-phase region will phase separate into a polymer-dense coacervate phase and a polymer-poor supernatant
phase, connected by a tie-line. While identical coacervate and supernatant phases will be formed from any sample prepared along
such a tie-line, the relative position on the line dictates the fraction of the resulting sample that will be coacervate vs. supernatant,
as per the lever rule. A sample prepared at relatively high polymer concentration (blue dot) will produce a much larger volume of
coacervate than one prepared at lower polymer concentrations (green). The relative volumes of coacervate (blue) and supernatant
(green) are indicated in the depicted vials. (d) Schematic depiction of the results of a stoichiometry experiment, which tests the
effect of changing the relative amounts of polycation and polyanion at constant total polymer concentration and constant solution
conditions. The turbidity signal maps out conditions where phase separation occurs. For the system where the degree of
ionization of the polymeric species is the same, a maximum in turbidity is observed at a charge fraction of 0.5 (red,
corresponding to the grey line in (a). This result shifts to a cationic charge fraction of 0.67 if the degree of ionization of the
polycation is half that of the polyanion (blue, corresponding to the grey line in (b)).

These same trends can be observed through a “stoichiometry” experiment, which typically uses
turbidity to determine the polymer ratio that gives maximum coacervate yield.18-24 A
stoichiometry experiment varies the relative amount of polycation to polyanion while keeping
the total polymer concentration constant (corresponding to the grey lines in Figure 1a,b). For
systems where the polycation and polyanion can be considered as fully ionized (or have equal
levels of ionization), the peak in the turbidity would be expected at a mole fraction of 0.5 with
respect to one of the polymer species, or a 1:1 equimolar ratio (Figure 1d, red curve). However,
if one of the polymer species is only half charged, this will result in a shift in the observed signal.

For instance, in the example shown in Figure 1b where only half of the monomers on the
polycation are ionized, a turbidity peak would be observed at a charge fraction of 0.67,
corresponding to the condition where two cationic monomers are needed for every one anionic
monomer, or a 1:2 ratio (Figure 1d, blue curve). This condition of charge neutrality identifies the
point where the maximum number of polymer chains will be incorporated into the coacervate
phase; complexation will still occur at off stoichiometric conditions, but with a decreased level
of coacervation. From a theoretical perspective, the composition of the bulk coacervate phase
should be the same, with the difference being purely one of yield. However, experimentally, the
preparation of off-stoichiometry dispersions of coacervate droplets can result in the recruitment
of excess polymer to the surface of the droplet, imparting colloidal stability.20,21
For a given ratio of polycation-to-polyanion, the phase diagram for coacervation is then shown
as a one-dimensional binodal curve, typically as a function of salt and total polymer
concentration (Figure 1c). This binodal curve represents the slice through the larger twodimensional phase space at constant polymer composition (i.e., the black line). Samples prepared
at a composition within this two-phase region will phase separate into two liquid phases, the
polymer-rich coacervate phase and the polymer-poor supernatant phase. The composition of the
resulting coacervate and supernatant phases is defined by the tie-line that connects these two
points. One interesting (and potentially unintuitive) result of this phase behavior is that
increasing the amount of polymer present in the initial sample mixture will not result in a
commensurate increase in the polymer concentration in the resulting coacervate phase. Instead,
samples prepared at different points along the tie-line will result in samples with different
quantities of the same coacervate phase, as defined by the lever rule. Samples prepared at higher
polymer concentrations will result in a larger coacervate volume, and vice versa.
There are numerous strategies for weakening or completely overcoming the interactions that
cause complex coacervation. For example, changes in the solution pH or the addition of an
excess of one of the polymers can shift the solution conditions outside of the two-phase
window.25,26 As suggested by Figure 1a-c, ionic strength is also an important variable for
controlling coacervation.10,11,20 The addition of salt can facilitate screening of the electrostatic
interactions and reduces the entropic gains associated with complexation.20,27 However, it is
important to define the conditions for which this salt dissolution is being defined. As shown in
Figure 1c, the critical point is the highest salt concentration for which phase separation can be
observed. However, most experiments do not operate near the critical condition and are therefore
interested in determining the concentration of salt above which phase separation is no longer
observed for a given sample condition. This salt concentration is typically referred to as the salt
resistance,28,29 and is dependent upon the choice of polymers, the coacervate composition, and
the identity of the salt used. As was discussed regarding the effects of polymer concentration on
coacervate composition, the salt resistance for any sample prepared along a given tie-line will be
the same. However because tie-lines for coacervation tend to be non-horizontal (i.e., there is
preferential partitioning of salt out of the coacervate phase), it is possible to change the salt
resistance by changing polymer concentration, although this usually requires a significant change
so as to move off of one tie-line and onto another.30 In the context of encapsulation studies, the
salt resistance is an important parameter because it determines the concentration of salt required
to dismantle the coacervate.
This introduction is intended to provide a foundational understanding of coacervate phase

behavior to facilitate the use of coacervation for protein encapsulation. Thus far, our discussion
has focused on complex coacervates formed from two species, a polycation and a polyanion.
While the addition of protein does not alter these design rules, the chemical complexity of
proteins can make interpretation of experimental data more challenging. For instance, most
proteins carry a mixture of positive and negative charges. While electrostatic intuition would
dictate that we consider only the net charge of a protein, there are examples where clustering of
charges has allowed for complex coacervation to occur “on the wrong side of the isoelectric
point,” such that it would appear that complexation is occurring between two species of the same
charge.31-34 It is also common to explore coacervation between a protein and two oppositely
charged polymers, particularly for cases where the protein of interest is only weakly charged.
10,11,35,36
In these cases it is necessary to consider the net charge of all three species, and to
carefully balance the ionic strength of the system, as changes in the salt concentration will
disfavor the incorporation of the more weakly charged protein in favor of stronger electrostatic
interactions between the two more strongly charged polymers.
In the following sections we will discuss experimental strategies to characterize the coacervation
phase behavior of a system of two oppositely charged polymers containing a protein cargo, as
well as the incorporation of protein into the coacervate phase. These methods are intended to be
general, and can be adapted to fit specific situations, such as the complexation of a protein with
only a single, oppositely charged polymer.

Materials, Equipment, and Reagents
The materials required for these experiments include two oppositely charged polyelectrolytes, a
protein of interest, salt, buffer (if desired), and acid/base for pH adjustments. We recommend
that all solutions of polymer, protein, buffer (if desired) and salt be adjusted to the same pH.
Coomassie Brilliant Blue G-250 dye can be purchased alone or as part of a Bradford Assay kit.
Samples will be prepared via pipetting in microcentrifuge tubes and transferred into well plates
(96- or 384-well plates are common. We recommend the use of a vortex mixer during sample
preparation, an optical microscope for sample visualization, and a plate reader with UV/vis
spectrophotometry capabilities. It is also possible to perform samples in cuvettes using a UV/vis
spectrophotometer. Turbidity measurements are typically performed at a wavelength of light in
the middle of the visible spectrum, and away from the absorbance peak of any of the materials
(~562 nm is common). For quantifying the concentration of protein present, the Coomassie dye
used in the Bradford assay is analyzed at a wavelength of 595 nm, and the experiment can be
performed in a well plate, cuvette, or other small volume UV/vis setup (e.g., NanoDrop). The use
of absorbance at 280 nm requires the use of either UV-compatible cuvettes or a NanoDrop-type
setup.

Safety Considerations
These techniques are safe to perform in a standard laboratory setting with the use of appropriate
personal protection equipment such as safety glasses, lab coats, and gloves. It is recommended
that experiments involving Coomassie dye be performed inside a chemical fume hood. For
specific materials, refer to the safety data sheets.
To keep solutions sterile and dust free, keep the lids on all reagents, removing the lid only when
pipetting, placing the cap back each time, though the lid may remain loose. Similarly, we

recommend keeping all microcentrifuge tubes closed except when adding solution or transferring
samples. The presence of dust can alter turbidity results. Care should also be taken to avoid
cross-contamination of samples from pipette tips.

Protocols
Characterizing Coacervate Phase Behavior
While the ultimate goal of an experiment might be the encapsulation of a target protein, we
recommend first characterizing the phase behavior of your coacervate system in terms of charge
stoichiometry and salt resistance. These information will help in the planning of experiments
related to protein encapsulation and will facilitate the interpretation of the resulting protein
encapsulation data. These experiments are typically performed at relatively low concentrations of
protein and polymer to limit reagent requirements. All experiments can be scaled up in terms of
volumes and/or concentrations, though it is important to ensure that all samples are fully mixed
and equilibrated.
Polymer-Polymer Stoichiometry Experiments
Stoichiometry experiments examine coacervate formation as a function of the ratio of polycation
to polyanion at constant polymer concentration. Thus, while polymer stock solutions can be
prepared at any concentration, we recommend the use of ionizable monomer concentration on a
molar basis. The use of monomer concentration circumvents issues with polymer polydispersity,
and allows for the easy analysis of results in terms of the stoichiometry of electrostatic
interactions. A stock solution concentration of 10 mM monomer is generally sufficient for
turbidity experiments.
A typical stoichiometry experiment will span the range of possible charge fractions, which we
will express in terms of the mole fraction of ionizable monomers of the polycation present in our
sample, to observe both a peak in the data, and clear baselines. The data in Figures 3 and 4 and
the experimental recipes listed in Tables 1 and 2 span the range of 0.1 to 0.9. These data points
can be equally spaced for initial experiments. However, once the location of the turbidity peak is
known (or if its location is estimated based on the charge state of the polymers), it is useful to
sample the concentration space around the peak more closely. Additionally, it is important to
ensure that the final polymer concentration in the prepared samples results in a sufficiently high
level of turbidity. This signal should be distinguishable from that of a blank solution at the same
salt/buffer concentration, but in the absence of polymer. In our experience, samples should be
prepared at a final concentration of at least 1 mM (with respect to the total number of monomers),
though this threshold concentration is a function of the path length through the sample.
To facilitate the preparation of fully equilibrated coacervate samples, we recommend that any
salt, buffer, and excess water are combined first, followed by the addition of one of the polymers.
It is then important to ensure that the sample is well mixed (e.g., vortexing for 5-10 s) before the
second polymer is added, and that the sample is mixed again after the addition of the second
polymer. It is also possible to prepare the polymer stock solutions at a specified concentration of
salt/buffer, thereby eliminating the need to add these components separately, though this
approach is less flexible in terms of adjusting experimental parameters. Once samples have been
prepared, they should be mixed well and transferred to a well plate or cuvette for turbidity
analysis. An example turbidity result for a stoichiometry experiment between poly(L-lysine) and

poly(D,L-glutamate), degree of polymerization N = 50, pH = 7.0 is shown in Figure 2a. The
coacervate samples, as formed, should be a dispersion of droplets that gives the sample a cloudy
and possibly opalescent appearance. At this point, the time between sample preparation and
analysis is an important consideration, as the coacervate droplets can coalesce and settle over
time and thus give variable turbidity readings. Generally, the turbidity signal should not be
sensitive to differences of a few minutes, though this time scale can vary significantly based on
the identity of the polymer system and the solution conditions.
Table 1: Sample preparation for complexation between poly(L-lysine) (K50) and poly(D,L-glutamate) (E50), degree of
polymerization N = 50, pH = 7.0. Components were added from right to left as outlined in the protocol. The final monomer
concentration is 1 mM.

Charge
Fraction
K50(+)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Blank

0.100
0.200
0.300
0.400
0.425
0.450
0.475
0.500
0.525
0.550
0.575
0.600
0.700
0.800
0.900
--

Volume
10mM
E50(-)
(µL)
10.8
9.6
8.4
7.2
6.9
6.6
6.3
6.0
5.7
5.4
5.1
4.8
3.6
2.4
1.2
0.0

Volume
10mM
K50(+)
(µL)
1.2
2.4
3.6
4.8
5.1
5.4
5.7
6.0
6.3
6.6
6.9
7.2
8.4
9.6
10.8
0.0

Volume
Water
Added
(µL)
108.0
108.0
108.0
108.0
108.0
108.0
108.0
108.0
108.0
108.0
108.0
108.0
108.0
108.0
108.0
120.0

Figure 2: Turbidity data from (a) stoichiometry experiments involving poly(L-lysine) and poly(D,L-glutamate) with a degree of
polymerization N = 50, pH 7.0 with no added buffer and (b) salt resistance experiments as a function of increasing NaCl
concentration. The final monomer concentration was 1 mM. Lines connecting the data points are a guide for the eye.

While all experimental results should be replicated in order to ensure reproducibility (i.e.
“technical” replicates), we also recommend that samples be prepared in such a way that each
sample can be split and analyzed separately (a repeat measurement of the sample, similar to a
“biological” replicate). The use of three replicates/repeats will allow for the statistical analysis of
the resulting data. In terms of sample preparation, the total volume of sample prepared for a
repeated measurement should be >3x the volume needed for the three individual samples. For
example, 35 µL of sample is needed for a turbidity measurement using a 384-well plate.
However, to ensure that sufficient sample volume is available for pipetting, a total sample
volume of 120 µL might be prepared.
After turbidimetry, samples should be inspected visually using an optical microscope. Standard
brightfield microscopy with a 40x objective is typically sufficient for this procedure, though
more advanced techniques such as phase contrast or differential interference contrast (DIC) can
enhance the ability to visualize samples. For samples prepared at low polymer concentration, it
may be difficult to distinguish very small droplets. The size of these coacervate droplets can be
increased either by increasing the polymer concentration present in the sample, or by allowing
the sample more time for the droplets to coalesce. The main goals in visualizing coacervate

samples are to confirm the liquid vs. solid nature of the resulting materials, and provide
secondary confirmation of trends (e.g., the presence or absence of coacervates) suggested via
turbidity. Coacervate droplets should appear as circular/spherical structures either floating in
solution or adhered onto a surface, whereas solid precipitation typically appears as fractal
aggregates (Figure 3).

Figure 3: Optical micrographs of (a) liquid complex coacervate droplets of poly(L-lysine) and poly(D,L-glutamate), and (b)
fractal solid precipitates resulting from the interaction of poly(L-lysine) and poly(L-glutamate). All samples were prepared using
polymers with degree of polymerization N = 100 at a total monomer concentration of 6 mM in 100 mM NaCl, pH 7.0.

An important consideration in the preparation of coacervates is whether they are fully
equilibrated. This question can be answered by testing whether or not the results of an
experiment are sensitive to the order of polymer addition.
Polymer-Polymer Salt Resistance Experiments
The goal of salt resistance experiments is to identify the concentration of salt (for a given total
polymer concentration and stoichiometric ratio) above which phase separation is no longer
observed. This provides information on the location of the binodal curve, and informs the design
of experimental procedures where dissolution of the coacervate phase is needed. The magnitude

of the salt resistance is dependent upon the length and identity of the polymers, the choice of salt,
the solution pH, etc. Generally speaking, increases in polymer length, hydrophobicity, and
charge density will result in higher values of the salt resistance at the same polymer
concentration.
In designing a salt resistance experiment for a new polymer, it may be necessary to perform a
screening-level experiment to identify the general range of salt concentrations over which the
experiment should be performed. Generally, the salt resistance can be identified as a clear
decrease in the turbidity signal with increasing salt concentration. However, it is useful to
combine turbidimetry measurements with direct visualization of the samples via optical
microscopy to confirm results. An example of salt resistance data for the system of poly(Llysine) and poly(D,L-glutamate) degree of polymerization N = 50, pH = 7.0 is shown in Figure
2b.
A general step-by-step protocol for these polymer-only experiments is given below.
Experimental Protocol for Coacervate Samples (no protein)
1. Set up microcentrifuge tubes for each sample and a blank, labeling appropriately.
2. Pipette the appropriate amount of water into each tube (as needed).
3. Pipette the appropriate amount of buffer solution into each tube (as needed).
4. Pipette the appropriate amount of salt solution into each tube (as needed).
5. Pipette the appropriate amount of the first polyelectrolyte solution into each tube.
6. Vortex each tube for 5-10 s.
7. Pipette the appropriate amount of the second polyelectrolyte solution into each tube,
vortexing for 5-10 s immediately after each addition.
8. Transfer aliquots of each sample to the well plate or cuvette for turbidity analysis.
9. Inspect each sample via optical microscopy.
Table 2: Sample preparation for a salt curve for between poly(L-lysine) (K50) and poly(D,L-glutamate) (E50), degree of
polymerization N = 50, in 10 mM HEPES buffer pH = 7.0. Components were added from right to left as outlined in the protocol.
The final monomer concentration is 1 mM.

1
2
3
4
5
6
7
8
9
10
11
12
13
14

Charge
Fraction
K50(+)

Volume
10mM
E50(-)
(µL)

Volume
10mM
K50(+)
(µL)

0.500
0.500
0.500
0.500
0.500
0.500
0.500
0.500
0.500
0.500
0.500
0.500
0.500
0.500

6.0
6.0
6.0
6.0
6.0
6.0
6.0
6.0
6.0
6.0
6.0
6.0
6.0
6.0

6.0
6.0
6.0
6.0
6.0
6.0
6.0
6.0
6.0
6.0
6.0
6.0
6.0
6.0

Volume
2M
NaCl
Added
(µL)
0.0
1.5
3.0
4.5
6.0
9.0
12.0
18.0
21.0
24.0
27.0
30.0
36.0
42.0

Volume
Water
Added
(µL)
108.0
106.5
105.0
103.5
102.0
99.0
96.0
90.0
87.0
84.0
81.0
78.0
72.0
66.0

15
16
Blank

0.500
0.500
--

6.0
6.0
0.0

6.0
6.0
0.0

48.0
54.0
0.0

60.0
54.0
120.0

Polymer-Polymer-Protein Stoichiometry Experiments
The design of a stoichiometry experiment for a system that combines protein in the presence of a
polycation and polyanion varies only slightly in design and intent. While more extensive
experiments that vary the relative amounts of each polymer and the quantity of protein can be
performed to map out the complete phase behavior of this more complex system, simpler
experiments that consider the effect of polymer charge stoichiometry in the presence of a
constant level of protein can also be performed (see Table 3 for an example recipe). Here, we
will discuss the design of these simpler experiments and how the addition of a protein as a third
charged macromolecule can alter the phase behavior of the system.
Table 3: Sample preparation for complexation between poly(L-lysine) (K50) and poly(D,L-glutamate) (E50), degree of
polymerization N = 50, in 10 mM HEPES buffer pH = 7.0 with bovine serum albumin (BSA). Components were added from
right to left as outlined in the protocol. The final monomer concentration is 7 mM and the final protein concentration is 50
µg/mL.

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Blank

Charge
Fraction
K50(+)

Volume
10mM
E50(-)
(µL)

Volume
10mM
K50(+)
(µL)

0.100
0.200
0.300
0.400
0.425
0.450
0.475
0.500
0.525
0.550
0.575
0.600
0.700
0.800
0.900
0.000

151.2
134.4
117.6
100.8
96.6
92.4
88.2
84.0
79.8
75.6
71.4
67.2
50.4
33.6
16.8
0.0

16.8
33.6
50.4
67.2
71.4
75.6
79.8
84.0
88.2
92.4
96.6
100.8
117.6
134.4
151.2
0.0

Volume 2
mg/mL
BSA(-)
Added
(µL)
6.0
6.0
6.0
6.0
6.0
6.0
6.0
6.0
6.0
6.0
6.0
6.0
6.0
6.0
6.0
0.0

Volume
0.5 M
HEPES
Added
(µL)
4.80
4.80
4.80
4.80
4.80
4.80
4.80
4.80
4.80
4.80
4.80
4.80
4.80
4.80
4.80
4.80

Volume
Water
Added
(µL)
61.2
61.2
61.2
61.2
61.2
61.2
61.2
61.2
61.2
61.2
61.2
61.2
61.2
61.2
61.2
235.2

Our initial stoichiometry experiments with just the two-polymer system served to identify the
composition corresponding to maximum coacervate yield, corresponding to a charge-neutral
mixture of the two polymers. However, the addition of a charged protein would be expected to
shift this optimal condition. As can be seen in Figure 4a, the addition of negatively-charged
bovine serum albumin (BSA) to a mixture of poly(L-lysine) and poly(D,L-glutamate) degree of
polymerization N = 50, in 10 mM HEPES, pH = 7.0 results in a shift in the resulting turbidity
signal to higher mole fractions of the polycation. A shift in the opposite direction, to “net
negative” conditions would be expected for positively-charged proteins. 35-37
As for the two-polymer system, it is important to determine whether the order of mixing has any

effect on the resulting coacervates.
Polymer-Polymer-Protein Salt Resistance Experiments
Salt resistance experiments can also be performed for samples including proteins. However, most
proteins would be expected to have a lower charge content and charge density than the
associated polymers. As such, it is a reasonable assumption that the salt resistance of the threemacromolecule system should be lower than that of the polymer-only system.

Figure 4: (a) Turbidity data from stoichiometry experiments involving poly(L-lysine) and poly(D,L-glutamate) with a degree of
polymerization N = 50 (black) and for the same system with the anionic protein bovine serum albumin (BSA) (red) in 10 mM
HEPES. The inset optical micrograph depicts the formation of coacervate droplets with BSA. (b) The corresponding
concentration of protein in the supernatant (black) and coacervate (red) phases, as determined using a Bradford assay. (Blocher
McTigue, W. C.; Perry, S. L. Design Rules for Encapsulating Proteins into Complex Coacervates. Soft Matter 2019, 15, 3089–
3103. Reproduced by permission of The Royal Society of Chemistry. Ref. [35].)

A general step-by-step protocol for these polymer-polymer-protein experiments is given below.
Experimental Protocol for Coacervate Samples (with protein)
1. Set up microcentrifuge tubes for each sample and a blank, labeling appropriately.
2. Pipette the appropriate amount of water into each tube (as needed).
3. Pipette the appropriate amount of buffer solution into each tube (as needed).
4. Pipette the appropriate amount of salt solution into each tube (as needed).

5. Pipette the appropriate amount of the first polyelectrolyte solution into each tube.
6. Vortex each tube for 5-10 s.
7. Pipette the appropriate amount of the protein solution into each tube, vortexing for 5-10 s
immediately after each addition.
8. Pipette the appropriate amount of the second polyelectrolyte solution into each tube,
vortexing for 5-10 s immediately after each addition.
9. Transfer aliquots of each sample to the well plate or cuvette for turbidity analysis.
10. Inspect each sample via optical microscopy.
Quantifying Protein Incorporation into Complex Coacervates
While turbidity and optical microscopy can be used to determine whether complexation has
occurred or not, these measurements do not provide information on the incorporation of protein
into the coacervate phase. Instead, separate measures of the protein concentration in the
coacervate and supernatant phases must be made, along with a determination of the volume of
each phase.
Once the concentrations for both the coacervate and supernatant phases are known, several other
parameters may be determined. The first is the encapsulation efficiency (EE) with is the
percentage of cargo (by mass) sequestered, in this case, by complex coacervates. Measuring the
supernatant volume and multiplying by the concentration of protein in the supernatant phase
gives the mass of cargo in the supernatant. Subtracting this mass from the total mass of protein
added to the system during sample preparation allows for calculation of the mass of protein in
the coacervate phase. These masses can then calculate the encapsulation efficiency:
𝐸𝐸 =

!!"#!. !"#$%&'
𝑥100%
!!"!#$ !"#$%&'

(1)

A partition coefficient, on the other hand, is typically defined as the ratio of the concentration of
protein in the dense coacervate phase over the concentration of the cargo in the dilute phase,
written as:
𝐾=

[!"#$%!"#!. !"#$%&' ]
[!"#$%!"#. !"#$%&' ]

(2)

Finally, loading or loading capacity is the amount of protein in the coacervate compared to the
total mass of the coacervate, i.e., it describes what fraction of the coacervate phase is comprised
of the cargo:
𝐿𝐶 =

!!"#!. !"#$%&'
𝑥100%
!!"#!. !"!#$

(3)

Below, we will detail strategies for assaying the protein concentration in coacervate samples
using a colorimetric Bradford assay, and via direct measurement of protein absorbance.
Bradford Assay
The protein quantification experiments described here are intended to be run in parallel with a
stoichiometry-type experiment, as described above, with half of the total sample volume used for
turbidity experiments, and the other half used for protein quantification. As in the case of
turbidity experiments, it is important to measure both repeat and replicate samples in order to

allow for statistical analysis of the results.
The Coomassie brilliant blue G-250 dye used in the Bradford assay is typically described as
interacting with basic amino acids in hydrophobic pockets, but primarily responds to arginine
residues, as well as histidine, tryptophan, tyrosine, and phenylalanine to a lesser extent.38-40
Typically, users buy a kit that may come with protein standards (e.g. bovine serum albumin,
BSA) to aid in the creation of a calibration curve. However, individual proteins interact
differently with the Coomassie dye, based on their amino acid sequence. Therefore, we
recommend creating calibration curves directly with the protein of interest. Furthermore, all
calibration curves must be prepared at the solution conditions (i.e., pH, salt concentration, etc.)
expected in the final sample. One consequence of this is that separate calibration curves are
required for supernatant samples, which can be measured directly, and coacervate samples,
which must be performed at a higher salt concentration in order to dismantle the coacervate
(Figure 5).
In addition to considering the specific interactions of the Coomassie dye with the protein at
different solution conditions, it is critical to determine the potential background signal that might
result from the dye interacting with the polymers used in the coacervate. While the interaction of
the dye with poly(L-lysine) and poly(D,L-glutamate) has been shown to be minimal,35 much
stronger interactions occur when more hydrophobic polymers such as poly(styrene sulfonate)
(PSS), poly(diallyldimethylammonium chloride) (PDADMAC), and methacrylate-based
polyelectrolytes. The interaction between polymer and dye can be tested by mixing a 1:1 volume
ratio of the dye with a solution of polymer at the concentration intended for use in experiments.
Qualitatively, a strong interaction between the dye and the polymers can be observed visually as
a color change from brackish-brown to blue. Quantitatively, it is important to consider whether
the level of background signal resulting from the polymers in the coacervate will swamp the
potential absorbance signal from the protein by itself. This comparison can be done via an
absorbance measurement at 595 nm. While it is possible to perform a background subtraction to
account for signal associated with the polyelectrolytes, this correction can become complicated if
the concentration of each of the polymers varies across different samples.
The linear range of the Bradford assay is a function of the specific interaction of the protein with
the Coomassie dye, and the volumetric scale (and thus the absorbance path length) at which the
experiment is performed. Different scale protocols have been developed for the Bradford assay
depending on the desired sample volumes and the range of concentrations. The main difference
in the protocols is the ratio of Coomassie Dye solution to protein sample. For example, the
“standard” Bradford protocol uses a 50:1 ratio of dye to sample, and has a typical range of ~1251,000 µg/mL. In contrast, the “micro assay” uses a 1:1 ratio of dye to sample and has a linear
range of approximately 1-10 µg/mL.39 These ratios, as well as the sample path length can be
tuned to optimize a protocol for a specific protein target and/or solution condition. For more
information on the Bradford assay, we encourage readers to refer to Refs. [38,39].
For the example data shown in Figure 4 and Table 3, we assayed the uptake of bovine serum
albumin (BSA) into coacervates formed from poly(L-lysine) and poly(D,L-glutamate) with a
degree of polymerization N = 50, in 10 mM HEPES, pH 7.0. The experiment tested the
incorporation of 50 µg/mL BSA as a function of the charge stoichiometry of the two polymers. A
“micro assay” style Bradford assay was used to quantify the protein concentration in both the

coacervate and the supernatant phases. Samples were prepared at a total volume of 240 µL, 105
µL of which was used for turbidity measurements (3 repeat samples of 35 µL each), and 115 µL
of which was used for protein quantification. After separating the coacervate and supernatant,
protocols were developed separately for the two phases.
Having measured the total volume of the supernatant for each sample to facilitate future mass
balance calculations, 115 µL of supernatant was then aliquotted into a clean microcentrifuge tube
and combined with an equal volume (115 µL) of 1x Coomassie dye. Three repeat aliquots of 35
µL each were then pipetted into a 384-well plate for absorbance measurements. The absorbance
data were converted to concentration values using a standard curve with samples prepared in 10
mM HEPES, pH 7.0.
For the coacervate samples, visual inspection after centrifugation had determined that the volume
of coacervate was very small (~0 – 2.2 µL). We then added 70 µL of 2.0 M NaCl to disassemble
the coacervate. This sample was then mixed with an equal volume (70 µL) of 1x Coomassie dye.
For these samples, we chose to neglect the volume of our coacervate in subsequent concentration
calculations as an error of ~0 – 2.2 µL represents a ~3% volume error. Three repeat aliquots of
35 µL each were then pipetted into a 384-well plate for absorbance measurements, as above. The
absorbance data for coacervate samples were converted to concentration using a standard curve
with samples prepared at a concentration of 2 M NaCl.
The data in Figure 4a show a strong peak in the turbidity at a mole fraction of polycation of
approximately 0.525. This peak in the turbidity data corresponds directly with a strong increase
in the concentration of protein present in the coacervate phase (to nearly 2.0 mg/mL, or 2,000
µg/mL), and a corresponding decrease in the protein from the supernatant (Figure 4b). In
contrast, for samples at the extremes of the stoichiometric range where no phase separation
occurred, we recovered the expected value of 50 µg/mL BSA that was input into the system.
Experimental Protocol for Protein Quantification Using the Bradford Assay
1. Perform steps 1-10 as described above for “Experimental Protocol for Coacervate
Samples (with protein).” Samples should be prepared at a volume scale 2x the quantity
needed for a turbidity experiment.
2. Centrifuge samples to phase separate the coacervate and supernatant phases for 20 min at
14,000 rpm (18,800 x g) at 15°C.
3. Use a pipette to transfer the supernatant into a new microcentrifuge tube carefully, noting
the volume.
* In many instances, such as the samples described in Table 3, it is difficult to
obtain accurate measurements of coacervate volumes that can be on the order of
~1 µL. To circumvent this issue, we can estimate this volume by subtracting the
measured value of the supernatant volume from the total sample volume.
4. Pipette a sufficient volume of a concentrated stock solution of salt (e.g., 2 M NaCl) to
cause the dissolution of the coacervate phase and create a large enough volume sample to
run multiple aliquots for the Bradford assay. The necessary concentration of salt can be
determined by a salt resistance experiment, as described above.
5. Pipette the necessary volume of Coomassie dye to the supernatant and coacervate
samples.
6. Vortex each tube for 5-10 s.

7. Transfer aliquots of the supernatant and coacervate samples into to the well plate or
cuvette, taking care to avoid and/or remove bubbles.
8. Measure the absorbance of the samples and a blank at 595 nm.
9. Convert the measured absorbance values to protein concentration using the appropriate
standard curve.
Utilizing Absorbance at 280 nm
While the Bradford assay is performed using a colorimetric readout, measuring absorbance at
280 nm (A280) requires special consideration. Many standard well plates and disposable
cuvettes may not be suited for this method as many plastics absorb in the UV. Specialized plastic
cuvettes, quartz cuvettes, and small volume absorbance setups such as the NanoDrop or Take3
should be used for these measurements.
The linear range of concentrations measurable by absorbance at 280 nm generally extends from
~20 µg/mL to ~3,000 µg/mL.41 However, the specific measurable range will be a function of the
extinction coefficient for a given protein, in tandem with potential background interference from
other components of the solution, as well as the path length of the sample. For example, the
standard range for the small volume NanoDrop system is between 0.1 mg/mL to 400 mg/mL for
BSA, which has an extinction coefficient of 43,824 M-1cm-1, assuming a molecular weight of
66.4 kDa.42 However, this range can be heavily influenced by the presence of other molecules
present in solution, such as salt, buffer, surfactants, etc. Table 3 lists the maximum allowable
concentration for a range of common chemicals related to these absorbance measurements.
In the specific context of complex coacervate samples, it is important to test whether or not the
polyelectrolytes used to form the coacervate absorb at 280 nm. While it is possible to perform a
background subtraction to account for signal associated with the polyelectrolytes, this correction
can become complicated if the concentration of each of the polymers varies across different
samples.
In each case, there is a known path length to use for l in Beer’s equation:
𝐴 = 𝑐𝜀𝑙

(4)

Additionally, the extinction coefficient used in the calculations will vary the calculated
concentrations. This coefficient can be found using programs such as ProtParam or looking into
the literature.43 If there is no known extinction coefficient and no sequence, a standard
assumption is that an absorbance reading of 1.0 is equal to 1 mg/mL based on a 0.1% or 1
mg/mL protein concentration producing an absorbance at 280 nm of 1.0 with a path length of 10
mm or 1 cm.40
In general, the molar extinction coefficient (in units of M-1cm-1) is approximated as:
𝜀 = 5500𝑊 + 1490𝑌 + 125𝐶

(5)

where W is the number of tryptophans, Y is the number of tyrosines, and C is the number of
cysteines in the protein sequence. Each number before the amino acids is the molar absorptivity
at 280 nm for that residue. It is noteworthy that extinction coefficients are frequently reported
using a range of different units, thus knowing the conversions is sometimes necessary for

analysis. To convert to a percent extinction coefficient, which has units of (g/100 mL)-1cm-1, the
formula is:
!"!

𝜀!% = !"

(6)

where MW is the molecular weight of the protein. Another common form is the 0.1% extinction
coefficient and has units of (mg/mL)-1cm-1. Converting to the 0.1% extinction coefficient
follows:
𝜀!.!% =

!%
!"

!

= !"

(7)

The use of a program to calculate protein concentration using absorbance at 280 nm may have
correction calculations, appropriate reading of the literature and user guides will help determine
such corrections. If it is suspected that the protein sample has nucleic contamination, Eq. 8 may
be used for an approximate determination:38,40
𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑚𝑔 𝑚𝐿 = 1.55 𝑥 𝐴!"# − 0.76 𝑥 𝐴!"#

(8)

However, a potentially simpler method for protein quantification at 280 nm is to create a
standard curve of the protein. This is useful for systems that employ various buffer conditions
that may affect results and does not require a NanoDrop program or use of an extinction
coefficient. Standard curves are made by preparing known sample concentrations at desired
conditions and running them at 280 nm, subtracting out a blank. It is good for scientists, however,
to understand where the math comes from if a NanoDrop or similar system is used. Note that
many of these systems have additional blank subtraction and correction procedures built in.
Experimental Protocol for Protein Quantification Using A280
1. Perform steps 1-4 as described above for the Bradford Protocol.
2. Pipette an aliquot of known volume for absorbance measurements.
a. A Take3 or NanoDrop system allow for the use of ~2 µL with a known path
length.
b. A UV-compatible cuvette can be used with a larger sample volume.
3. Measure the absorbance of the samples and a blank at 280 nm.
4. Convert the measured absorbance values to protein concentration using the appropriate
standard curve.
5. Samples will be read at 280 nm via a well plate reader
a. Take3 / NanoDrop have built in programs for 280 nm and are recommended for
specific moieties, such as BSA and IgG, with appropriate extinction coefficients
b. A standard curve may be used to determine protein concentration if extinction
coefficient is unknown or the extinction coefficient can be calculated via code or
from another program such as ProtParam.43
Standard Curves
For all of the methods described, it is necessary to create a standard curve to determine the
concentration of protein from the measured absorbance signal. While BSA is commonly used as
a protein standard to generate a “universal” set of standard curves, the colorimetric signal from
the Coomassie dye and/or the absorbance at 280 nm can vary widely from protein to protein, and

as a function of solution conditions. Thus, we advise the creation of a standard curve for each
protein at every set of experimental conditions used. Table 4Error! Reference source not found.
outlines limits for several common buffers, salts, etc. for the Bradford assay and 280 nm.40
Generally speaking, measurements at 280 nm are sensitive to molecules that have double bonds
between carbons or carbon and oxygen,40 while the Bradford assay does not tolerate high
concentrations of detergents.38
Table 4: Concentration limits for protein assays using Coomassie dye and absorbance at 280 nm. Values adapted from Olson and
Markwell Assays for Determination of Protein Concentration.38

Concentration Limits for Protein Assaysa
Substanceb

Dyec

280 nmd

HCl

0.1 M

>1 M

NaOH

0.1 M

>1 M

Acids and Bases

PCA

10%

TCA

10%

Buffers
Acetate

0.6 M

0.1 M

Ammonium sulfate

1M

>50%

Citrate

50 mM

5%

Glycine

0.1 M

1M

HEPES

100 mM

Phosphate

2M

1M

Tris

2M

0.5 M

Detergents
Brij 35

1%

CHAPS

10%

Deoxycholate

0.25%

0.30%

Digitonin

10%

Lubrol PX

10%

Octylglucoside

10%

SDS

0.10%

0.10%

Triton X-100

0.10%

0.02%

Triton X-100(R)

>10%

Tween 20

0.30%

Reductants
Dithiothreitol

1M

3 mM

2-Mercaptoethanol

1M

10 mM

DNA/RNA

0.25 mg

1 µg

Miscellaneous
DMSO

20%

EDTA

0.1 M

30 mM

Glycerol

100%

40%

KCl

1M

100 mM

NaCl

5M

>1 M

Sucrose

1M

2M

Urea

6M

>1 M

a

This table is a guide. Test buffer mixtures as described in the text. Values preceded by (<) or (>) symbols indicate that that
tolerable limit for the chemical is unknown but is, respectively, less than or greater than the amount shown. Blank spaces indicate
data were unavailable.
b

PCA, Perchloric acid; TCA, trichloroacetic acid; HEPES, N-2-hydroxyehtylpiperazine-N’-2-ethanesulfonic acid; CHAPS, 3[(3-cholamidopropyl)dimethylammino]propanesulfonic acid; SDS, sodium dodecyl sulfate; (R), reduced; DMSO, dimethyl
sulfoxide; EDTA ehtylenediamine-tetracetic acid.
c

Values indicate the concentration of the chemical in a 25 µL sample.

d

Values indicate the final concentration of the chemical which does not produce an absorbance of 0.5 compared to an equivalent
water blank.

Based on the various limits of detection for the different methods and the anticipated
concentrations of proteins, standard curves should be prepared at the relevant solution conditions
for the supernatant and coacervate samples. It is recommended that standard curves have at least
five points and completely span the range of interest. Example standard curves corresponding to
the supernatant and coacervate samples from Figure 4 are shown in Figure 5.

Figure 5: Standard curves for BSA for a Bradford assay under 10 mM HEPES (black open circles) with a 1:1 dye to sample ratio
and 2 M NaCl (red squares) with a 1:1 dye to sample ratio corresponding to the supernatant and coacervate phases. The black
lines represent linear fits.

The best practice is to make new curves for every new cargo as they vary from protein to protein
as seen comparing the curves from Figure 5 and Figure 6a. Additionally, varying the ratio of dye
to sample can change the linear range of a protein. In the case of hen egg white lysozyme
(HEWL), a ratio of two parts dye to one part sample is used to extend the range to 50 µg/mL
(Figure 6a). If the same ratio was used as for BSA in Figure 5, the result is no longer linear
(Figure 6b). The more dye added, the longer the linear range, this also allows for smaller sample
volumes.

(a)
R2= 0.98

R2= 0.99

(b)

Water

Figure 6: (a) Standard curves for HEWL for a Bradford assay under 10 mM HEPES (black open circles) with a 2:1 dye to
sample ratio and 2 M NaCl (blue squares) with a 1:1 dye to sample ratio corresponding to the supernatant and coacervate phases.
(b) Standard curve for HEWL for a Bradford assay in water with a 1:1 dye to sample ratio, which shows a shorter linear range.
The black lines represent linear fits to the data.

Table 5 shows an example recipe for a standard curve is outlined in Figures 5 and 6 to create a
curve that would place the target concentration in the middle of the range at pH 7 in 10 mM
HEPES. The goal is to create a linear curve over the desired range of concentrations using the
Bradford. A curve for both the supernatant and coacervate phases is required. The supernatant
will have the conditions set by sample preparation, while the coacervate phase will necessitate
whatever conditions are used to dismantle the dense phase, i.e. 2 M NaCl. To change Table 5
from the supernatant phase, take the total volume of buffer (HEPES) and water and add that
amount of salt.

Table 5: Standard curve example table for bovine serum albumin (BSA) or hen egg white lysozyme (HEWL) for the supernatant
phase. Total solution volume is 120 µL and can be used for a 96 (120 µL/well) or 384-well plate (35 µL/well x3).

Point
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Blank

[Protein]
(µg/mL)
1
5
10
15
20
25
30
35
40
45
50
55
60
65
70
0

0.2 mg/mL Protein
(µL)
0.6
3.0
6.0
9.0
12.0
15.0
18.0
21.0
24.0
27.0
30.0
33.0
36.0
39.0
42.0
0

0.5 M HEPES
(µL)
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.4
2.4

Water
(µL)
117.0
114.6
111.6
108.6
105.6
102.6
99.6
96.6
93.6
90.6
87.6
84.6
81.6
78.6
75.6
117.6

Analysis and Statistics
To facilitate statistical analysis, repeat samples and replicate experiments should be performed at
least three times. A standard t-test or ANOVA may be used for comparison between assay results.
Moving beyond raw data to calculated values such as the concentration of protein in the
coacervate phase, the encapsulation efficiency, partitioning, etc. require propagation of error.
Furthermore, propagation of error should be considered when performing baseline subtraction.
To obtain an equation for the propagated error use:
𝛿𝑅 =

!

!"

𝛿𝑥
!"

+

!"

𝛿𝑦
!"

!

+⋯

(9)

where R is the function whose error is being calculated and is a function of x, y, etc. The partial
derivative of R for a specific independent variable is multiplied by the error of that variable and
the whole quantity squared. This is done for each variable for which R is dependent and summed
together. Finally, the square root of the summation is taken and that is the error for R. For
example, the propagated error associated with performing a baseline subtraction between
averaged values of the sample and baseline absorbance is:
𝛿𝐴!"#,! =

!
!"

𝐴!"# − 𝑏 𝛿𝑏

!

+

!
!!!"#

𝐴!"# − 𝑏 𝛿𝐴!"#

!

(10)

This type of calculation should be performed for each mathematical manipulation performed
during data analysis. When using a standard curve, there is an associated error with the fit, which
should be included using error propagation. This error can be determined by using Eq. 9.

Summary
Complex coacervates are a novel materials platform for the encapsulation and delivery of a wide
range of materials, including proteins. We have discussed strategies for understanding the phase
behavior associated with the coacervation of polymeric systems in the absence and presence of
protein, along with methods for measuring the concentration of protein in coacervate samples.
Here we have shown that it is possible to use established methods and adapt them to coacervate
systems for protein analysis.
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